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Warthin tumor-like papillary thyroid carcinoma is an uncommon variant of papillary thyroid carcinoma. We report a rare case
of Warthin tumor-like variant of papillary thyroid carcinoma with a dediﬀerentiated component consisting of a solid tumor area
composedofneoplasticcellswithaspindletotallcellmorphologyassociatedwithmarkednuclearpleomorphism,atypicalmitoses,
and foci of necrosis. Although our patient presented with a locally aggressive disease (T3 N1b Mo), she is disease-free without
radioiodine therapy after a 23-month follow-up period. We emphasize that Warthin tumor-like papillary thyroid carcinoma, like
other morphological variants of papillary carcinoma, may occasionally undergo dediﬀerentiation. As this component may be only
focally detectable, we suggest an extensive sampling of all large-sized (>3cm) papillary thyroid carcinoma. Recognition of any
dediﬀerentiated component in a Warthin tumor-like papillary thyroid carcinoma should be reported, including its percentage,
because it may reﬂect a more aggressive clinical course.
1.Introduction
Warthin tumor-like papillary thyroid carcinoma, ﬁrst
described in 1995 by Apel et al. [1], is a relatively uncommon
variant of papillary thyroid carcinoma (PTC) with about 80
cases reported in the English literature to date [2–11]. The
term “Warthin tumor-like PTC” was ﬁrst coined on the basis
of its close morphological resemblance to Warthin tumor,
characteristically occurring in the salivary glands [1, 3, 4].
Clinically,itusuallypresentsasacysticorsolid-cysticthyroid
nodule [1–5]. Histologically it is composed of papillae lined
by large, polygonal cells with abundant eosinophilic, ﬁnely
granular cytoplasm, with a core exhibiting dense chronic
inﬂammatory inﬁltrate, consisting predominantly of lym-
phocytes and plasmacells. Fine needle aspiration cytology
(FNAC) and the histological examination of Warthin tumor-
like PTC can pose diagnostic diﬃculties in distinguishing
this neoplasm from a ﬂorid chronic thyroiditis, H¨ urthle cell
nodules in chronic lymphocytic thyroiditis [11, 12], H¨ urthle
cell tumors, tall cell and oncocytic variants of PTC, and,
lastly, oncocytic variant of medullary carcinoma [12]. As
far as diﬀerential diagnosis with lymphocytic thyroiditis are
concerned, it is particularly intriguing that Warthin tumor-
like PTC can be frequently documented in the context of
Hashimoto thyroiditis [1–3, 11], representing a potential
diagnostic pitfall. However, the main diagnostic criterion
for diagnosis of Warthin tumor-like PTC is the detection of
the typical nuclear features commonly seen in conventional
typePTC,namely,opticallyclearnuclei,nucleargrooves,and
intranuclear pseudoinclusions. Molecular biology studies
have shown that Warthin tumor-like PTC and conventional
PTC share the same BRAF and RET mutations, supporting
that the former is a morphological variant of the latter [6].
However, whether Warthin tumor-like PTC should be con-
sidered a distinct clinico-pathologic entity with a favourable
prognosis is still matter of debate [1, 3, 5, 7, 9], because
some authors have reported that about 30% of cases exhibit
a tendency to lymph nodal metastases and extrathyroidal
extension [8, 9, 11]. The possibility of PTC to undergo
dediﬀerentiation is a rare but well-known event which has2 Case Reports in Medicine
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Figure1:FNACshowingalargeneoplasticpapilla(a)andnumerousmono-orbi-nucleatedpolygonaltospindle-shapedcellswithabundant
eosinophiliccytoplasmandlargenucleiwithﬁnelydispersedchromatinandoneortwoprominentnucleoli;somecellsshowmarkednuclear
pleomorphism (b).
ap r o g n o s t i ci m p a c t[ 4, 8, 13, 14]. Dediﬀerentiation usually
consists of tumor solid areas characterized by plump spindle
and squamoid cells with pleomorphic nuclei, in association
withscatteredareasofnecrosis.HighmitoticindexandMIB-
1labellingindexareusuallyassociatedfeatures[8,13].A“tall
cell” component can be also documented [8]. The presence
of dediﬀerentiation in a PTC is usually associated with a
worse prognosis, unless it is only focally detectable [8, 13,
14]. To the best of our knowledge, only one case of Warthin
tumor-like PTC with a dediﬀerentiated component (10% of
the entire tumor) has been reported in the literature [8].
As this tumour behaved aggressively, with diﬀuse inﬁltration
of adjacent organs, distant metastases, and death of patient
18 months after thyroid surgery, the authors used the term
“Warthin tumor-like variant of papillary thyroid carcinoma
with dediﬀerentiation (anaplastic changes)” [8]. We herein
report the clinico- pathological features of an unusual case
of Warthin tumor-like PTC exhibiting a minor (about 5%)
dediﬀerentiated component, consisting of marked nuclear
pleomorphism, high mitotic index, atypical mitoses, tumor
necrosis, and spindle to tall cell changes. Although our
patient presented with a locally aggressive disease (T3 N1b
M0), she is disease-free without radioiodine therapy after a
23-monthfollow-upperiodbymeansofclinicalandimaging
(TC) evaluation.
2. Patient Proﬁle
A 79-year-old Caucasian woman presented at our observa-
tion for a swelling of the anterior neck. Clinical evaluation
revealed a left thyroid mass and a swelling of the omolateral
cervical region. Thyroid function blood tests revealed a
high level of thyroglobulin protein (283ng/ml), with no
abnormalities for fT3, fT4, and TSH. An ultrasound was
performed and showed a 52 × 47 × 61mm solid-cystic
mass, located in the left thyroid lobe and extending into
mediastinum with deviation of the trachea. In addition,
voluminous hypoechogenous nodular masses, suspicious
for omolateral laterocervical lymph node metastases, were
found.
3.CytologicalFindings
FNAC of the left thyroid mass was performed, showing
several clusters and numerous papillae (Figure 1(a))o f
polygonaltospindle-shapedcellswithabundanteosinophilic
cytoplasm and large nuclei with ﬁnely dispersed chromatin
and one or two prominent nucleoli, suggestive of oncocytic
cells (Figure 1(b)). Some of these cells showed marked
nuclear pleomorphism and mitoses. Only rarely nuclear
grooves could be identiﬁed. Some neoplastic cells were bi- or
multinucleated. Numerous large-sized multinucleated giant
cells and a small amount of lymphocytes were also present.
FNACoflaterocervicalmassesshowedredbloodcells,granu-
locytes and clusters of oncocytic cells with mild atypia, in the
absence of colloid and lymphoid cells. Cytological diagnosis
was consistent with PTC, oncocytic variant, with lymph
node metastases. Patient underwent total thyroidectomy and
lymphadenectomy with laterocervical, recurrent nerve, and
left jugular vein lymph nodes excision.
4.GrossFindings
Grossly, the left thyroid lobe was completely replaced by
two nodules, measuring respectively 9 and 5cm in greatest
diameter, the former being solid and yellowish in colour
(Figure 2), the latter solid-cystic with a central hemorrhagic
area. Right thyroid lobe showed typical features of multin-
odular goiter.
5.HistologicalFindings
Histological examination of left thyroid lobe revealed a
tumor with a predominant papillary architecture. Tumor
papillae were lined by oncocytic cells showing the typi-
cal nuclear features of PTC, namely, chromatin clearing,
pseudonuclear inclusions, and grooves (Figure 3). The pap-
illary stalks were entirely occupied by a dense inﬂamma-
tory inﬁltrate, predominantly consisting of lymphocytes
(Figure 3). Numerous multinucleated giant cells were also
present. Notably, some tumor areas, with an overall diameterCase Reports in Medicine 3
Figure 2: Gross examination. The left thyroid lobe is completely
replaced by two nodules which, on cut section, are yellowish in
colour.
of 0.8cm, had a solid growth pattern and were composed
of neoplastic cells exhibiting marked nuclear pleomorphism,
consisting of large-sized vescicular or hyperchromatic round
to oval nuclei with one or more large nucleoli (Figure 4(a)).
In addition some neoplastic cells showed both tall and
spindle cell changes (Figure 4(a)). Mitotic activity ranged
from 1 to 4 mitoses ×10 high-power ﬁeld (HPF) and
rare atypical mitoses were seen. Foci of tumor necro-
sis were also seen (Figure 4(b)). Tumor invaded thyroid
capsule extending into perithyroidal adipose soft tissue.
Immunohistochemically, neoplastic cells were diﬀusely and
strongly stained with galectin-3, HBME-1, CK19, TTF-1,
thyroglobulin, EMA, cytokeratins AE1/AE3, S-100 protein,
and cyclin-D1 (Figure 5). The dediﬀerentiated component
was positive to all above-mentioned antibodies and addi-
tionally to vimentin (focal expression). Focal expression of
p53 was observed either in the classical tumour component
or in the dediﬀerentiated component. The MIB-1 labelling
index was about 2-3% in the classical oncocytic papillary
thyroid carcinoma component and approximately 7% in
the dediﬀerentiated component. Lymphocytes contained in
the ﬁbrovascular core of the papillae were represented by
a mixture of T- and B-lymphocytes (CD3 + and CD20
+). Multinodular goiter was histologically conﬁrmed in the
right lobe. Ten regional lymph nodes, including omolateral
laterocervical ones, were positive for metastasis. No tumour
dediﬀerentiated component could be identiﬁed in lymph
nodes metastases. Based on these pathological features, a
diagnosis consistent with “Warthin tumor-like PTC with a
minor (5%) dediﬀerentiated component” was rendered.
6. Discussion
Warthin tumor-like PTC is a relatively uncommon variant
of PTC. The present study deals with a rare case of Warthin
tumor-like PTC with a minor (5%) dediﬀerentiated compo-
nent. Lam and colleagues in 2005, for the ﬁrst time, reported
a similar case with an aggressive biological behaviour and
patient death [8]. Accordingly, these authors used the term
“anaplastic changes” to describe the worrisome morphologi-
cal features consisting, like in our case, of a solid tumor area
characterizedbyspindletoovoidtotallcellsshowingmarked
Figure 3: Histological examination of tumor showing the typical
features of Warthin tumor-like PTC: papillae lined by oncocytic
cells showing the typical nuclear features of PTC, and containing
a dense inﬂammatory inﬁltrate, predominantly consisting of lym-
phocytes.
(a)
(b)
Figure 4: Dediﬀerentiation: tumor area composed of neoplastic
cells with a spindle cell morphology and marked nuclear pleomor-
phism (a). Foci of tumor necrosis were scattered throughout the
tumor (b).
nuclear atypia, high MIB-1 labelling index (20%), and foci
of necrosis. In our case, atypical mitoses were an additional
ﬁnding of the dediﬀerentiated component. Interestingly, we
showed that cyclin-D1 was overexpressed throughout the
tumor, including dediﬀerentiated component. This ﬁnding
would support previously published data suggesting that a4 Case Reports in Medicine
Figure 5: Most neoplastic cells showing a diﬀuse immunostaining
with cyclin-D1.
high cyclin-D1 expression is usually associated with locally
advanced disease in PTC [15–17]. Despite our case showed
an overlapping morphology as compared to the previously
described case by Lam et al. [8], our patient is well after a
23-month follow-up period from surgery. This apparently
diﬀerent clinical course may be explained by the fact that
the patient reported by Lam et al., despite a FNA-based
diagnosis of PTC, declined surgical treatment. Subsequently,
she returned 3 years later with a signiﬁcant increase in size
of her thyroid mass and associated local symptoms due to
diﬀuse tumor extension. It is likely that the minor (5%)
dediﬀerentiated component of our case was not enough to
impart tumor the ability to invade adjacent organs and/or
distantmetastases.Onthecontrary,wecanspeculatethatthe
dediﬀerentiated component in the case of Lam et al. was not
present at the time of cytological diagnosis, developing later,
or alternatively, although it could be present at diagnosis,
it increased over a period of three years, up to represent
the 10% of the entire tumor component at surgery. We
would like to emphasize that also Warthin tumor-like PTC,
like other morphological variants of PTC, may occasionally
undergo dediﬀerentiation and that this tumor component
may be only focally detectable. Accordingly, we suggest
that large-sized (>3cm) Warthin tumor-like PTCs should
be extensively sampled to exclude the presence of any
dediﬀerentiated component. The present case, along with
that previously reported [8], suggests that even a minor
(5%–10%) dediﬀerentiated component in an otherwise
typical Warthin tumor-like PTC has a prognostic impact.
In fact both cases were presented with a locally advanced
disease, that is, extrathyroidal extension plus lymph node
metastasis and recurrent nerve involvement, respectively, in
our case and in that by Lam et al. [8]. We suggest that
the term “anaplastic changes” to indicate a dediﬀerentiated
component in an otherwise speciﬁed Warthin tumor-like
PTC should be abandoned to avoid confusion with true
anaplasticcarcinomapotentiallyarisingfromaPTC[13,14].
The clinical evidence that our patient is disease-free after
a 23-month follow-up from a radical surgical treatment,
led us to prefer the term “Warthin tumor-like PTC with a
minor dediﬀerentiated component” for such tumors. Lastly,
we recommend that, like in typical PTC, the percentage of
the dediﬀerentiated component should always be reported,
because the survival rate of patient is likely dependent on its
extension within tumor. Studies on large series could help to
identify the exact size of the dediﬀerentiated component that
reﬂects a worse clinical behaviour.
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